Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.
Document Type
Journal Article
Publication Date
7-15-2015
Student Program
IBS
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Volume
21
Issue
14
Inclusive Pages
3149–3159
DOI
10.1158/1078-0432.CCR-14-1421
APA Citation
Katz, S., Burga, R., McCormack, E., Wang, L., Mooring, W., Point, G., Khare, P., Thorn, M., Ma, Q., Stainken, B., Assanah, E., Davies, R., Espat, N., & Junghans, R. (2015). Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.. Clinical cancer research : an official journal of the American Association for Cancer Research, 21 (14). http://dx.doi.org/10.1158/1078-0432.CCR-14-1421
Peer Reviewed
1
Open Access
1
